Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension

被引:31
作者
Shaw, Duncan [1 ]
Hollingworth, Greg [1 ]
Soldermann, Nicolas [2 ]
Sprague, Elizabeth [3 ]
Schuler, Walter [2 ]
Vangrevelinghe, Eric [2 ]
Duggan, Nicholas [1 ]
Thomas, Matthew [1 ]
Kosaka, Takatoshi [1 ]
Waters, Nigel [1 ]
van Eis, Maurice J. [2 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 5AB, W Sussex, England
[2] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland
[3] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
关键词
Rho kinase; Inhibitors; Lymphocyte depletion; Pulmonary arterial hypertension; Intra-tracheal dosing; RHO-KINASE INHIBITOR; PHYSIOLOGY; REVEALS;
D O I
10.1016/j.bmcl.2014.09.002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of selective inhibitors of ROCK1 and ROCK2 has been identified by structural based drug design. PK/PD experiments using a set of highly selective Rho kinase inhibitors suggest that systemic Rho kinase inhibition is linked to a reversible reduction in lymphocyte counts. These results led to the consideration of topical delivery of these molecules, and to the identification of a lead molecule 7 which shows promising PK and PD in a murine model of pulmonary hypertension after intra-tracheal dosing. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4812 / 4817
页数:6
相关论文
共 19 条
[1]   Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity [J].
Anastassiadis, Theonie ;
Deacon, Sean W. ;
Devarajan, Karthik ;
Ma, Haiching ;
Peterson, Jeffrey R. .
NATURE BIOTECHNOLOGY, 2011, 29 (11) :1039-U117
[2]   Targeting RhoA/ROCK pathway in pulmonary arterial hypertension [J].
Antoniu, Sabina Antonela .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) :355-363
[3]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[4]  
Chen H. H., 1875, BIOORG MED CHEM LETT, V2014, P24
[5]   Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension [J].
Do E, Zhulanqiqige ;
Fukumoto, Yoshihiro ;
Takaki, Aya ;
Tawara, Shunsuke ;
Ohashi, Junko ;
Nakano, Makoto ;
Tada, Tomohiro ;
Saji, Kenya ;
Sugimura, Kohichiro ;
Fujita, Hiroshi ;
Hoshikawa, Yasushi ;
Nawata, Jun ;
Kondo, Takashi ;
Shimokawa, Hiroaki .
CIRCULATION JOURNAL, 2009, 73 (09) :1731-1739
[6]   Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities [J].
Doe, Chris ;
Bentley, Ross ;
Behm, David J. ;
Lafferty, Robert ;
Stavenger, Robert ;
Jung, David ;
Bamford, Mark ;
Panchal, Terry ;
Grygielko, Eugene ;
Wright, Lois L. ;
Smith, Gary K. ;
Chen, Zunxuan ;
Webb, Christine ;
Khandekar, Sanjay ;
Yi, Tracey ;
Kirkpatrick, Robert ;
Dul, Edward ;
Jolivette, Larry ;
Marino, Joseph P. ;
Willette, Robert ;
Lee, Dennis ;
Hu, Erding .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01) :89-98
[7]   Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase [J].
Fagan, KA ;
Oka, M ;
Bauer, NR ;
Gebb, SA ;
Ivy, DD ;
Morris, KG ;
McMurtry, IF .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (04) :L656-L664
[8]   Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension [J].
Fujita, Hiroshi ;
Fukumoto, Yoshihiro ;
Saji, Kenya ;
Sugimura, Koichiro ;
Demachi, Jun ;
Nawata, Jun ;
Shimokawa, Hiroaki .
HEART AND VESSELS, 2010, 25 (02) :144-149
[9]   Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension - A Pilot Efficacy Trial - [J].
Fukumoto, Yoshihiro ;
Yamada, Norikazu ;
Matsubara, Hiromi ;
Mizoguchi, Minori ;
Uchino, Kazuaki ;
Yao, Atsushi ;
Kihara, Yasuki ;
Kawano, Mitsuhiro ;
Watanabe, Hiroshi ;
Takeda, Yutaka ;
Adachi, Takeshi ;
Osanai, Shinobu ;
Tanabe, Nobuhiro ;
Inoue, Teruo ;
Kubo, Akihiro ;
Ota, Yuri ;
Fukuda, Koichiro ;
Nakano, Takeshi ;
Shimokawa, Hiroaki .
CIRCULATION JOURNAL, 2013, 77 (10) :2619-2625
[10]   Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension [J].
Ishikura, K ;
Yamada, N ;
Ito, M ;
Ota, S ;
Nakamura, M ;
Isaka, N ;
Nakano, T .
CIRCULATION JOURNAL, 2006, 70 (02) :174-178